SCHEMBL476692

SCHEMBL476692

CCc1cc2cccc(Cl)c2n1CCCNS(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.40
RECQL P46063 1/20 0.40
PIK3CD O00329 1/20 0.37
PIK3R2 O00459 1/20 0.37
PIK3CG P48736 1/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
NQO2 P16083 1/20 0.36
CNR2 P34972 1/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
TDP1 Q9NUW8 3/20 0.35
KCNJ5 P48544 2/20 0.35
KCNJ3 P48549 2/20 0.35
MEN1 O00255 2/20 0.34
TP53 P04637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476604 0.85 RECQL (0.41) TLR7RECQLPIK3CDPIK3R2PIK3CG
SCHEMBL476711 0.72 PTGS1 (0.39) PIK3CDPIK3R2PIK3CGHTTPOLB
SCHEMBL476619 0.71 ALDH1A1 (0.39) TLR7RECQLHTTPOLBCNR2
SCHEMBL476538 0.71 SMN1; SMN2 (0.40) TLR7HTTLMNAPOLBNQO2
SCHEMBL476681 0.71 MEN1 (0.39) TLR7PIK3CDPIK3R2PIK3CGHTT
SCHEMBL476594 0.69 ALDH1A1 (0.37) TLR7POLBCNR2CYP1A2CYP3A4
SCHEMBL476636 0.69 HTR7 (0.39) HTTLMNAPOLBCYP1A2CYP3A4
SCHEMBL5660343 0.69 MEN1 (0.42) TLR7RECQLPIK3CDPIK3R2PIK3CG
SCHEMBL476641 0.67 MEN1 (0.61) HTTPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL5657653 0.66 CNR2 (0.42) TLR7HTTCNR2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951225-B1 3-ACYLINDOLE DERIVATIVES THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-02-01 EP disclosed
US-7741363-B2 3-Acylindole derivatives, preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2010-06-22 US disclosed
US-20080275102-A1 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275102-A1 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF F12, ECI1, NQO2 TLR7 924/4885RECQL 420/4885PIK3CD 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.